After more than eight months of the spread of the Corona pandemic in the world, starting from the “Wuhan of China”, the basis of the epidemic, and with the registration of nearly eleven million infected people around games, the European Commission has today approved the use of the drug “Remisdiver” to treat severe cases after infection with the Corona virus, which appears in European Union, according to the Italian agency «Aki».
The decision came after a recommendation last week by the European Medicines Agency (EMA) to use the drug to treat patients from 19 co-workers who are at least 12 years old, who have pneumonia and need oxygen.
Earlier, a number of countries, including the United States, South Korea, Japan, and Egypt, had adopted “treatments” to treat Covid-19, and Health Commissioner Stella Kyriakides said in a press release that “we will spare no effort to ensure an effective treatment or vaccine against the virus”. , And the approval of the European Union executive authority to use this drug as a last step for the first approved treatment in Europe to treat the epidemic.
In another context, and with the efforts of scientists around the world, beginning to know the symptoms of the disease until the methods of treatment, a recent Swedish study revealed what can be considered a “surprise” about immunity to the Corona virus, which has infected more than 11 million people in the world until now since its first appearance in China. Last December, contrary to what many medical tests have shown about the human body not being sufficiently immune to infection with the Corona virus, the study confirmed that the immunity to the virus may be higher than what tests show.
–
